Natalie Gukasyan, MD

Psychiatry
Accepting New Patients
Virtual Visits/Telehealth
Profile Headshot

Overview

Dr. Natalie Gukasyan is an Assistant Professor of Psychiatry at Columbia University Irving Medical Center. She graduated from Cornell University where her undergraduate studies focused on biology and nutrition. She attended medical school at Tulane University and went on to complete residency in psychiatry at Johns Hopkins Hospital. She then went on to complete a research fellowship at the Johns Hopkins Behavioral Pharmacology Research Unit under the mentorship of Dr. Roland Griffiths, where she led a pilot study of psilocybin-assisted therapy for individuals with anorexia nervosa and studied long-term outcomes of patients receiving psilocybin therapy for major depressive disorder. After fellowship Dr. Gukasyan served as the inaugural Medical Director of the Johns Hopkins Center for Psychedelic and Consciousness Research.

Areas of Expertise / Conditions Treated

  • Addiction
  • Substance Use

Academic Appointments

  • Assistant Professor of Psychiatry at CUMC

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.

Schedule Virtual Visit

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Location(s)

Insurance Accepted

Aetna

  • Aetna Signature Administrators
  • HMO
  • NYP Employee Plan
  • NY Signature
  • Student Health

CHP Student Health

  • CHP-NYU

Elderplan

  • Medicare Managed Care

Emblem/HIP

  • EPO
  • POS
  • PPO

Fidelis Care

  • Medicare Managed Care

Medicare

  • Railroad
  • Traditional Medicare

Quality Health Management

  • Quality Health Management

UnitedHealthcare

  • Behavioral Health (Columbia University Employee Plan)

World Trade Center Health Plan

  • World Trade Center Health Plan

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

  • MD, Tulane University School of Medicine
  • BS, Human Biology, Health, and Society, Cornell University
  • Residency: The Johns Hopkins University School of Medicine
  • Fellowship: Johns Hopkins University School of Medicine, Behavioral Pharmacology Research Unit

Board Certifications

  • Psychiatry

Research

Dr. Gukasyan's research interests focus on understanding and optimizing the safety and efficacy of psychedelic-assisted therapy and other novel mental health interventions.

Selected Publications

  1. Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. J Psychopharmacol. 2022 Feb;36(2):151-158. doi: 10.1177/02698811211073759. PMID: 35166158; PMCID: PMC8864328.
  2. Raison CL, Sanacora G, Woolley J, Heinzerling K, Dunlop BW, Brown RT, Kakar R, Hassman M, Trivedi RP, Robison R, Gukasyan N, Nayak SM, Hu X, O'Donnell KC, Kelmendi B, Sloshower J, Penn AD, Bradley E, Kelly DF, Mletzko T, Nicholas CR, Hutson PR, Tarpley G, Utzinger M, Lenoch K, Warchol K, Gapasin T, Davis MC, Nelson-Douthit C, Wilson S, Brown C, Linton W, Ross S, Griffiths RR. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA. 2023 Sep 5;330(9):843-853. doi: 10.1001/jama.2023.14530. Erratum in: JAMA. 2024 Feb 27;331(8):710. doi: 10.1001/jama.2024.0828. PMID: 37651119; PMCID: PMC10472268.
  3. Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, Griffiths RR. Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. J Psychopharmacol. 2021 Apr;35(4):437-446. doi: 10.1177/0269881120967878. Epub 2021 Jan 9. PMID: 33427007; PMCID: PMC8056708.
  4. Gukasyan N, Nayak SM. Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy. Transcult Psychiatry. 2022 Oct;59(5):652-664. doi: 10.1177/1363461520983684. Epub 2021 Jan 26. PMID: 33499762.
  5. Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR. Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports. Pharmacopsychiatry. 2021 Sep;54(5):240-245. doi: 10.1055/a-1524-2794. Epub 2021 Aug 4. PMID: 34348413.